Prostatic Neoplasms: all 6,484 studies
Page 35 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 BeforeCompletedNCT04587427
- Economic Evaluation of Robot-assisted Laparoscopic Radical Prostatectomy vs Conventional Laparoscopic Radical Prostatectomy and Open Retropubic Radical Prostatectomy in Prostate Cancer: a Real-life Study Based on the French National Healthcare Data System (SNDS)Status unknownNCT04587284
- Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate AdenocarcinomaStatus unknownNCT04586543Phase 2
- Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART StudyWithdrawnNCT04585932Phase 2
- Stockholm3 Validation Study in a Multi-Ethnic CohortCompletedNCT04583072
- Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate CancerCompletedNCT04582656Not applicable
- Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)TerminatedNCT04581109Not applicable
- Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation ToxicityWithdrawnNCT04580667
- A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate CancerActive, not recruitingNCT04577833Phase 1
- Re-treatment 225Ac-J591 for mCRPCCompletedNCT04576871Early Phase 1
- A Study of FT-7051 in Men With MCRPCTerminatedNCT04575766Phase 1
- Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer PatientsActive, not recruitingNCT04575402
- A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic ProstatectomyCompletedNCT04574401Phase 1
- Effectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3Status unknownNCT04573179
- Prostate Imaging Using MRI +/- Contrast EnhancementActive, not recruitingNCT04571840Not applicable
- Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)WithdrawnNCT04569461Phase 2
- Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic CarcinomaStatus unknownNCT04567875
- Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer PatientsWithdrawnNCT04565496Phase 2
- Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®CompletedNCT04563936Phase 3
- PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate CancerActive, not recruitingNCT04560725Not applicable
- Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese PatientsCompletedNCT04560452
- Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)CompletedNCT04558866Phase 2
- Impact of Exercise on Mitochondria in Cancer Patients.CompletedNCT04558398Not applicable
- PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate CancerActive, not recruitingNCT04557501Phase 3
- A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerActive, not recruitingNCT04557059Phase 3
- Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate CancerCompletedNCT04556045Not applicable
- 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)CompletedNCT04553926
- TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate CancerActive, not recruitingNCT04552509Not applicable
- Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsActive, not recruitingNCT04550494Phase 2
- Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility StudyCompletedNCT04550416Not applicable
- mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate CancerCompletedNCT04545697Not applicable
- Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsTerminatedNCT04541225Phase 1
- Integrated Genomic Prostate Score With MRI Targeted Prostate BiopsiesActive, not recruitingNCT04541030
- Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by MetforminActive, not recruitingNCT04536805Phase 1/2
- Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.TerminatedNCT04535908Not applicable
- Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized TrialCompletedNCT04534075Phase 3
- Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over ChemotherapyCompletedNCT04533958Not applicable
- [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate CancerTerminatedNCT04528199Phase 1
- HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate CancerStatus unknownNCT04523896Phase 2
- Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT04521686Phase 1
- White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CASuspendedNCT04519879Phase 2
- Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGOCompletedNCT04516707
- EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)CompletedNCT04516161
- Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialActive, not recruitingNCT04513717Phase 3
- [177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.CompletedNCT04509557Phase 1
- INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate CancerStatus unknownNCT04507698Not applicable
- Improvement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative ConversationsStatus unknownNCT04506710
- Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesCompletedNCT04501913
- Anesthesia in PROstate Biopsy Pain Obstruction StudyCompletedNCT04501055Not applicable
- Feasibility and Safety of Physical Exercise in Men With Prostate CancerCompletedNCT04500080Not applicable
- Dynamic Whole Body PET/ MRIWithdrawnNCT04495959
- Stereotactic Body Radiotherapy (SBRT) for Localized Prostate CancerStatus unknownNCT04489745Phase 2
- 18F-PSMA-1007 PET Imaging to Detect Primary Prostate CancerCompletedNCT04487847Phase 1/2
- SC10914 Monotherapy for the mCRPC With g/s BRCA MutationStatus unknownNCT04486937Phase 1/2
- Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)WithdrawnNCT04486846Not applicable
- Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)Active, not recruitingNCT04486755Phase 1
- RESIST-ADT (Androgen Deprivation Therapy)CompletedNCT04485767Not applicable
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersActive, not recruitingNCT04485013Phase 1
- Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyActive, not recruitingNCT04484818Phase 3
- [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate CancerActive, not recruitingNCT04484701
- Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation TherapyCompletedNCT04484246
- RPCRC Validation StudyStatus unknownNCT04484103
- Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate CarcinomaStatus unknownNCT04484038Not applicable
- 68Ga PSMA-11 PET/CT in Recurrent Prostate CancerWithdrawnNCT04483414Phase 2
- A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsActive, not recruitingNCT04478279Phase 1/2
- ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT04471974Phase 2
- A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)Active, not recruitingNCT04471727Phase 1/2
- Impact of Acetazolamide in Reducing Referred Postoperative PainCompletedNCT04470843Phase 1
- EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate CancerActive, not recruitingNCT04465500Phase 2
- Mobile Sensor Technologies to Assess General Symptomology of People With CancerCompletedNCT04465214
- Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedStatus unknownNCT04462926Not applicable
- Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage TubeStatus unknownNCT04457882Not applicable
- Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerTerminatedNCT04457245Phase 3
- Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology ValidationActive, not recruitingNCT04457232Phase 1
- A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyActive, not recruitingNCT04455750Phase 3
- Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerApproved for marketingNCT04452136
- Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET StudyCompletedNCT04447703Not applicable
- Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate CancerCompletedNCT04443062Phase 2
- Artificial Intelligence for Prostate Cancer Treatment PlanningCompletedNCT04441775
- Safety and Feasibility of Reversible Induction StrategyStatus unknownNCT04434963
- Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to ProstatectomyActive, not recruitingNCT04430192Phase 1/2
- Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerCompletedNCT04428788Phase 1
- Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World SettingCompletedNCT04425200
- Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen TherapyCompletedNCT04424654Phase 2
- Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical ProstatectomyTerminatedNCT04423913Phase 2
- Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary ResultsCompletedNCT04421781
- Oral EPI-7386 in Patients with Castration-Resistant Prostate CancerTerminatedNCT04421222Phase 1
- Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate CancerTerminatedNCT04409288Phase 3
- Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® TestingActive, not recruitingNCT04404894
- A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).TerminatedNCT04404140Phase 1
- Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the ProstateWithdrawnNCT04403568Early Phase 1
- Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate CancerWithdrawnNCT04399824Not applicable
- Detection Rate of Prostate Cancer in Men Undergoing MRICompletedNCT04398173
- A Study of JNJ-70218902 in Participants With Advanced Stage Solid TumorsCompletedNCT04397276Phase 1
- Cost Talk: Discussing Cancer Care CostsCompletedNCT04397016Not applicable
- Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerActive, not recruitingNCT04396808Not applicable
- A Prospective Trial on Nerve Sparing Techniques Performed in Radical ProstatectomyTerminatedNCT04393831Not applicable
- Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate CancerCompletedNCT04389918Not applicable
- DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell CancersActive, not recruitingNCT04388852Phase 1
- MRI-guided Focal Laser AblationStatus unknownNCT04379362Phase 2